Abstract
Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Current Psychopharmacology
Title:Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder
Volume: 5
Author(s): Deepak Moyal, Amit Khanna, Vishal Dhiman and Aninda Sidana
Affiliation:
Keywords: Agranulocytosis, clozapine, eosinophilia, neutropenia, schizoaffective disorder, second generation antipsychotics.
Abstract: Background: Clozapine induced granulocytopenia has gained wide attention and effective monitoring has been able to prevent a number of untoward deaths. However, other myelodysplasias induced by Clozapine are still unrecognized and unreported. Another clinical complication of Clozapine is eosinophilia. However, this entity is unrecognized as the focus is mostly on granulocytopenia and neutropenia.
Objective: To describe a case of Clozapine induced eosinophilia without any other clinical or biochemical abnormalities induced by Clozapine.
Methodology: The file records of a patient with Schizoaffective disorder who developed eosinophilia while receiving Clozapine were studied and analyzed.
Results: The patient with Schizoaffective disorder who was on Clozapine with stringent monitoring developed eosinophilia with eosinophil counts rising up to 2850, with a fall in neutrophil counts up to 2320, all of which was reversed after stopping Clozapine.
Conclusion: Clozapine induced eosinophilia should also be considered as one of the important side effects along with neutropenia and leukopenia. Along with neutropenia and leukopenia it might be a manifestation of undergoing immunological abnormality associated with Clozapine.
Export Options
About this article
Cite this article as:
Moyal Deepak, Khanna Amit, Dhiman Vishal and Sidana Aninda, Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder, Current Psychopharmacology 2016; 5 (1) . https://dx.doi.org/10.2174/2211556005666160310001856
DOI https://dx.doi.org/10.2174/2211556005666160310001856 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antibody - Fc Receptor Interactions in Antimicrobial Functions
Current Immunology Reviews (Discontinued) Animal Models of Lupus and Lupus Nephritis
Current Pharmaceutical Design Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design Serpins for Diagnosis and Therapy in Cancer
Cardiovascular & Hematological Disorders-Drug Targets Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets Antagonism by Bioactive Polyphenols Against Inflammation: A Systematic View
Inflammation & Allergy - Drug Targets (Discontinued) Clinical and Pharmacological Aspects of Inflammatory Demyelinating Diseases in Childhood: An Update
Current Neuropharmacology Recent Advances in Characterizing Natural Products that Regulate Autophagy
Anti-Cancer Agents in Medicinal Chemistry Mediterranean Diet, Brain and Muscle: Olive Polyphenols and Resveratrol Protection in Neurodegenerative and Neuromuscular Disorders
Current Medicinal Chemistry Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Severe Influenza: Clinical Features and Treatment Options
Current Respiratory Medicine Reviews Current Status of Molecular Imaging in Inflammatory and Autoimmune Disorders
Current Pharmaceutical Design Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
Current Drug Safety Recent Insights into COVID-19 in Children and Clinical Recommendations
Current Pediatric Reviews Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design From a Dull Enzyme to Something Else: Facts and Perspectives Regarding Aldose Reductase
Current Medicinal Chemistry A Case of Pulmonary Tuberculosis Mimicking as Diffuse Alveolar Hemorrhage: A Case Report
New Emirates Medical Journal Update on Intravenous Immunoglobulins (IVIg) Mechanisms of Action and Off- Label use in Autoimmune Diseases
Current Pharmaceutical Design Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
Current Cardiology Reviews